Company Focus
Moderna
Latest Moderna News
Biotechnology
Moderna has reported third-quarter 2024 revenues of $1.9 billion, marking a slight increase from the $1.8 billion posted in the same period in 2023. 7 November 2024
Related News
Insights
Company Spotlight
A biopharma company developing products for the treatment of human disease, including immunology, metabolism, cardiology and ophthalmology.
Latest News & Features of interest to Moderna
Biotechnology
The US Food and Drug Administration (FDA) has approved a new indication for Darzalex Faspro, (daratumumab and hyaluronidase-fih) from US healthcare giant Johnson & Johnson. 31 July 2024
Pharmaceutical
Shares in UK pharma major GSK were 2% lower in London’s early afternoon trading on Wednesday. 31 July 2024
Pharmaceutical
US pharma giant Pfizer has reported its first quarter of sales growth since COVID-19 revenue peaked in late 2022. 30 July 2024
Pharmaceutical
Shares in Merck & Co were more than 10% lower during Tuesday’s early trading in New York after the US pharma giant announced its second-quarter financial results and latest guidance for 2024. 30 July 2024
Pharmaceutical
German infectious disease specialist AiCuris Anti-infective Cures has announced the appointment of Cynthia Wat as chief medical officer (CMO). 30 July 2024
Biotechnology
The month of July celebrated World Sjögren's Day, dedicated to Sjögren's syndrome (SS) – a condition affecting between 0.5% and 1% of the population.1 30 July 2024
Biotechnology
Boehringer Ingelheim today said it is taking a significant step in expanding its oncology pipeline of cancer cell-directed and immuno-oncology offering. 30 July 2024
Biotechnology
Dutch drug developer NewAmsterdam Pharma today announced what it called positive top-line data from the company’s Phase III BROOKLYN clinical trial (NCT05425745). 29 July 2024
Biotechnology
The National Institute for Health and Care Excellence (NICE) has published final guidance which does not recommend Enhertu (trastuzumab deruxtecan) for treating advanced HER2-low breast cancer in adults in England. 29 July 2024
Biotechnology
GSK and USA-based biotech incubator Flagship Pioneering have entered a collaboration with the goal of discovering and developing a portfolio of future transformational medicines and vaccines. 29 July 2024
Latest In Brief for Moderna
Biotechnology
GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS). 4 October 2024
Latest Relevant Ones To Watch News
California, USA-based biotech Nektar Therapeutics’ shares closed up more than 8% at $1.33 yesterday after it announced the sale of its only manufacturing facility. 5 November 2024
18 October 2024
24 September 2024
23 September 2024
16 September 2024
23 August 2024
22 August 2024
Relevant Ones to Watch Companies
Refine Search
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze